Journal article · 2024 · Open access

Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

Alize J Ferrari, Damian Francesco Santomauro, Amirali Aali, Yohannes Habtegiorgis Abate, Cristiana Abbafati, Hedayat Abbastabar, Samar Abd ElHafeez, Michael Abdelmasseh, Sherief Mohamed Abd-Elsalam, Arash Abdollahi, Auwal Abdullahi, Kedir Hussein Abegaz and 1,316 more

The Lancet, 403(10440), 2133–2161 · Published 17 April 2024 · DOI 10.1016/s0140-6736(24)00757-8

Read the free full textCite this paper

In brief

“Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021” is a 2024 journal article by Alize J Ferrari and 1,327 co-authors, published in The Lancet. OpenAlex counts 5,958 citations as of 15 November 2026. It is open access under a CC BY licence: the full text is free to read at The Lancet.

Citations
5,958
Most cited in
2025 (3,041)
Field-weighted impact
1947.72
References
41
Authors
1,328

Abstract

BACKGROUND: Detailed, comprehensive, and timely reporting on population health by underlying causes of disability and premature death is crucial to understanding and responding to complex patterns of disease and injury burden over time and across age groups, sexes, and locations. The availability of disease burden estimates can promote evidence-based interventions that enable public health researchers, policy makers, and other professionals to implement strategies that can mitigate diseases. It can also facilitate more rigorous monitoring of progress towards national and international health targets, such as the Sustainable Development Goals. For three decades, the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) has filled that need. A global network of collaborators contributed to the production of GBD 2021 by providing, reviewing, and analysing all available data. GBD estimates are updated routinely with additional data and refined analytical methods. GBD 2021 presents, for the first time, estimates of health loss due to the COVID-19 pandemic. METHODS: The GBD 2021 disease and injury burden analysis estimated years lived with disability (YLDs), years of life lost (YLLs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries using 100 983 data sources. Data were extracted from vital registration systems, verbal autopsies, censuses, household surveys, disease-specific registries, health service contact data, and other sources. YLDs were calculated by multiplying cause-age-sex-location-year-specific prevalence of sequelae by their respective disability weights, for each disease and injury. YLLs were calculated by multiplying cause-age-sex-location-year-specific deaths by the standard life expectancy at the age that death occurred. DALYs were calculated by summing YLDs and YLLs. HALE estimates were produced using YLDs per capita and age-specific mortality rates by location, age, sex, year, and cause. 95% uncertainty intervals (UIs) were generated for all final estimates as the 2·5th and 97·5th percentiles values of 500 draws. Uncertainty was propagated at each step of the estimation process. Counts and age-standardised rates were calculated globally, for seven super-regions, 21 regions, 204 countries and territories (including 21 countries with subnational locations), and 811 subnational locations, from 1990 to 2021. Here we report data for 2010 to 2021 to highlight trends in disease burden over the past decade and through the first 2 years of the COVID-19 pandemic. FINDINGS: Global DALYs increased from 2·63 billion (95% UI 2·44-2·85) in 2010 to 2·88 billion (2·64-3·15) in 2021 for all causes combined. Much of this increase in the number of DALYs was due to population growth and ageing, as indicated by a decrease in global age-standardised all-cause DALY rates of 14·2% (95% UI 10·7-17·3) between…

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Ferrari, A. J., Santomauro, D. F., Aali, A., Abate, Y. H., Abbafati, C., Abbastabar, H., ElHafeez, S. A., Abdelmasseh, M., Abd-Elsalam, S. M., Abdollahi, A., Abdullahi, A., Abegaz, K. H., Zúñiga, R. A. A., Aboagye, R. G., Abolhassani, H., Abreu, L. G., Abualruz, H., Abu‐Gharbieh, E., Abu-Rmeileh, N. M., . . . Murray, C. J. L. (2024). Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet, 403(10440), 2133–2161. https://doi.org/10.1016/s0140-6736(24)00757-8

MLA 9

Ferrari, Alize J, et al. “Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021.” The Lancet, vol. 403, no. 10440, 2024, pp. 2133–2161. https://doi.org/10.1016/s0140-6736(24)00757-8.

Chicago

Ferrari, Alize J, Damian Francesco Santomauro, Amirali Aali, Yohannes Habtegiorgis Abate, Cristiana Abbafati, Hedayat Abbastabar, Samar Abd ElHafeez, et al. 2024. “Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021.” The Lancet 403 (10440): 2133–2161. https://doi.org/10.1016/s0140-6736(24)00757-8.

Harvard

Ferrari, A. J. et al. (2024) ‘Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021’, The Lancet, 403(10440), pp. 2133–2161. doi:10.1016/s0140-6736(24)00757-8.

IEEE

A. J. Ferrari et al., “Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021,” The Lancet, vol. 403, no. 10440, pp. 2133–2161, 2024, doi: 10.1016/s0140-6736(24)00757-8.

BibTeX

@article{ferrari2024global,
  title     = {{Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021}},
  author    = {Ferrari, Alize J and Santomauro, Damian Francesco and Aali, Amirali and Abate, Yohannes Habtegiorgis and Abbafati, Cristiana and Abbastabar, Hedayat and ElHafeez, Samar Abd and Abdelmasseh, Michael and Abd-Elsalam, Sherief Mohamed and Abdollahi, Arash and Abdullahi, Auwal and Abegaz, Kedir Hussein and Zúñiga, Roberto Ariel Abeldaño and Aboagye, Richard Gyan and Abolhassani, Hassan and Abreu, Lucas Guimarães and Abualruz, Hasan and Abu‐Gharbieh, Eman and Abu-Rmeileh, Niveen ME and Ackerman, Ilana N. and Addo, Isaac Yeboah and Addolorato, Giovanni and Adebiyi, Akindele Olupelumi and Adepoju, Victor Abiola and Adewuyi, Habeeb Omoponle and Afyouni, Shadi and Afzal, Saira and Afzal, Sina and Agodi, Antonella and Ahmad, Aqeel and others},
  journal   = {The Lancet},
  year      = {2024},
  volume    = {403},
  number    = {10440},
  pages     = {2133--2161},
  doi       = {10.1016/s0140-6736(24)00757-8},
  url       = {https://doi.org/10.1016/s0140-6736(24)00757-8}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201911
202011
202111
202311
2024506506
20253,0413041
20262,4072407

Its field-weighted citation impact is 1947.72: it has been cited 1947.72 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Global Health and Epidemiology

  • disease burden
  • years lived with disability
  • disability-adjusted life years
  • healthy life expectancy
  • years of life lost
  • disability weights
  • disease prevalence
  • mortality

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Ferrari, A. J., Santomauro, D. F., Aali, A., Abate, Y. H., Abbafati, C., Abbastabar, H., ElHafeez, S. A., Abdelmasseh, M., Abd-Elsalam, S. M., Abdollahi, A., Abdullahi, A., Abegaz, K. H., Zúñiga, R. A. A., Aboagye, R. G., Abolhassani, H., Abreu, L. G., Abualruz, H., Abu‐Gharbieh, E., Abu-Rmeileh, N. M., . . . Murray, C. J. L. (2024). Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet, 403(10440), 2133–2161. https://doi.org/10.1016/s0140-6736(24)00757-8

How many times has this paper been cited?

5,958 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access: read the free full text at The Lancet.

Who wrote this paper?

Alize J Ferrari, Damian Francesco Santomauro, Amirali Aali, Yohannes Habtegiorgis Abate, Cristiana Abbafati, Hedayat Abbastabar, Samar Abd ElHafeez, Michael Abdelmasseh, Sherief Mohamed Abd-Elsalam, Arash Abdollahi, Auwal Abdullahi, Kedir Hussein Abegaz and 1,316 more.

What is the DOI of this paper?

10.1016/s0140-6736(24)00757-8. The permanent link is https://doi.org/10.1016/s0140-6736(24)00757-8.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.